Creso Pharma acquires U.S. company in $21 million all-stock deal

CBD Products & CBD Business News

Share this:

Nutraceuticals maker Creso Pharma Ltd. said it signed an agreement to acquire Colorado-based consumer packaged goods company Sierra Sage Herbs (SSH) in an all-stock deal worth $21 million.

Australia-based Creso Pharma said it intends to take a 100% interest in SSH through subsidiary Creso Pharma US, giving the company a strong foothold in the U.S. market.

What Creso gains

The deal provides Creso Pharma a platform to introduce its CBD products to U.S. consumers through SSH relationships with large retail groups representing 90,000 points of sale, and more than 150,000 direct consumer customers. The company also takes over SSH’s established suite of products including a line of CBD.

Founded in 2008, SSH, based in Lyons, Colorado, had gross revenues of $5.7 million in 2021, down from $8 million in 2020. That falloff is attributable to delays in the acquisition process with Creso Pharma, which impacted digital marketing and product procurement, according to a Creso Pharma press release.

Creso Pharma said it intends to appoint SSH co-founder and CEO Jodi Scott as Executive Director and President of US Operations.

Articles You May Like

New initiative to legalize recreational marijuana aims to make the ballot in 2024
Weeding out the facts about medical marijuana
Medical marijuana and drug tests for work
Cannabis & Hemp Education on The Green Rush 8/12/22
This Is How Pot Edibles Are Made | Originals | msnbc

Leave a Reply

Your email address will not be published.